BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 3319041)

  • 1. Effects on dopamine metabolism of MPTP and MPP+ infused through a push-pull cannula into the caudate nucleus of awake adult male rats.
    Chang GD; Ramirez VD
    Brain Res; 1987 Oct; 424(1):49-57. PubMed ID: 3319041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
    Sirinathsinghji DJ; Heavens RP; McBride CS
    Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanism of action of MPTP and MPP+ on endogenous dopamine release from the rat corpus striatum superfused in vitro.
    Chang GD; Ramirez VD
    Brain Res; 1986 Mar; 368(1):134-40. PubMed ID: 3485463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effects of 1-methyl-4-phenylpyridinium ion (MPP+) on dopamine and serotonin metabolism in rat striatum as assayed in vivo by a micro-dialysis technique.
    Ozaki N; Nakahara D; Kaneda N; Kiuchi K; Okada T; Kasahara Y; Nagatsu T
    J Neural Transm; 1987; 70(3-4):241-50. PubMed ID: 3500274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurochemical changes in the substantiae nigrae and caudate nuclei following acute unilateral intranigral infusions of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Sirinathsinghji DJ; Whittington PE; Audsley AR
    Brain Res; 1986 Dec; 399(2):339-45. PubMed ID: 2435361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged alterations in canine striatal dopamine metabolism following subtoxic doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 4'-amino-MPTP are linked to the persistence of pyridinium metabolites.
    Johannessen JN; Sobotka TJ; Weise VK; Markey SP
    J Neurochem; 1991 Sep; 57(3):981-90. PubMed ID: 1677682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of the in vivo catabolism of exogenous dopamine as infused through a push-pull cannula implanted in the rat caudate nucleus.
    Chang GD; Ramirez VD
    Brain Res; 1989 Mar; 481(2):265-73. PubMed ID: 2720380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The toxic actions of MPTP and its metabolite MPP+ are not mimicked by analogues of MPTP lacking an N-methyl moiety.
    Bradbury AJ; Costall B; Domeney AM; Testa B; Jenner PG; Marsden CD; Naylor RJ
    Neurosci Lett; 1985 Oct; 61(1-2):121-6. PubMed ID: 2417166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral and biochemical changes following acute administration of MPTP and MPP+.
    Tadano T; Satoh N; Sakuma I; Matsumura T; Kisara K; Arai Y; Kinemuchi H
    Life Sci; 1987 Mar; 40(13):1309-18. PubMed ID: 2436017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesencephalic dopamine neurons become less sensitive to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity during development in vitro.
    Danias P; Nicklas WJ; Ofori S; Shen J; Mytilineou C
    J Neurochem; 1989 Oct; 53(4):1149-55. PubMed ID: 2788714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective decrease in extracellular DOPAC concentrations in rat striatum following in vivo dialysis with low concentrations of MPP+.
    Caliguri EJ; Johannessen JN
    Brain Res; 1991 May; 548(1-2):94-9. PubMed ID: 1714336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of 1-methyl-4-phenylpyridinium ion (MPP+) on the efflux and metabolism of endogenous dopamine in rat striatal slices.
    Snape BM; Pileblad E; Ekman A; Magnusson T; Carlsson A; Engel J
    J Pharm Pharmacol; 1988 Sep; 40(9):620-6. PubMed ID: 2907028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased caudate dopamine turnover may contribute to the recovery of motor function in marmosets treated with the dopaminergic neurotoxin MPTP.
    Rose S; Nomoto M; Kelly E; Kilpatrick G; Jenner P; Marsden CD
    Neurosci Lett; 1989 Jul; 101(3):305-10. PubMed ID: 2505199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: the effect of perinigral infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, its metabolite and their analogs in the rat.
    Harik SI; Schmidley JW; Iacofano LA; Blue P; Arora PK; Sayre LM
    J Pharmacol Exp Ther; 1987 May; 241(2):669-76. PubMed ID: 2437293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity.
    Heikkila RE; Nicklas WJ; Vyas I; Duvoisin RC
    Neurosci Lett; 1985 Dec; 62(3):389-94. PubMed ID: 3912685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of intracerebrally administered MPP+ (1-methyl-4-phenylpyridinium) in three species: microdialysis of dopamine and metabolites in mouse, rat and monkey striatum.
    Rollema H; Alexander GM; Grothusen JR; Matos FF; Castagnoli N
    Neurosci Lett; 1989 Dec; 106(3):275-81. PubMed ID: 2601882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--I. Behavioural, neurochemical and histological characterization of the lesion.
    Sirinathsinghji DJ; Heavens RP; Richards SJ; Beresford IJ; Hall MD
    Neuroscience; 1988 Oct; 27(1):117-28. PubMed ID: 3264391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolism and 1-methyl-4-phenylpyridinium uptake in dissociated cell cultures from the embryonic mesencephalon.
    Schinelli S; Zuddas A; Kopin IJ; Barker JL; di Porzio U
    J Neurochem; 1988 Jun; 50(6):1900-7. PubMed ID: 3259619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the tyrosine hydroxylase system by MPTP, 1-methyl-4-phenylpyridinium ion (MPP+) and the structurally related compounds in vitro and in vivo.
    Nagatsu T; Hirata Y
    Eur Neurol; 1987; 26 Suppl 1():11-5. PubMed ID: 2884110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure to detect 6-hydroxydopamine in rat striatum after the dopamine releasing drugs dexamphetamine, methylamphetamine and MPTP.
    Rollema H; De Vries JB; Westerink BH; Van Putten FM; Horn AS
    Eur J Pharmacol; 1986 Dec; 132(1):65-9. PubMed ID: 3102260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.